Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol versus propofol in high-BMI surgical patients
ChiCTR2500101725Phase 4Not yet recruiting
- Sponsor
- Chengdu Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Apr 2025
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium and propofol in obesity and lipid metabolism disorder (2 arms), sponsored by Chengdu Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoints: Liver function, Lipid profile and 1 more. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
fospropofol disodiumpropofol
03
Conditions
obesitylipid metabolism disorder
Beyond the preview
Go deeper on ChiCTR2500101725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101725.